Compare Apple Inc (AAPL) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Apple Inc vs Health Care Select Sector SPDR Fund — how do they compare? Apple Inc trades at $314.35 (market cap $4.56T), while Health Care Select Sector SPDR Fund trades at $163.04. The key difference: Apple Inc pays a 0.35% dividend while Health Care Select Sector SPDR Fund pays none. Which is the better fit depends on your goals.
| AAPL | XLV | |
|---|---|---|
Market Cap | $4.56T | — |
Volume | 100,358,844 | — |
Sector | Technology | — |
52-Week High | $315.20 | $164.48 |
52-Week Low | $202.38 | $129.01 |
Enterprise Value | $4.58T | — |
Dividend Yield | 0.35% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Apple (AAPL) trades at $314.13, up 0.47% today, with a bullish technical outlook and strong institutional support. The stock shows robust fundamentals with 2025 revenue of $416.16B and net income of $112.01B, beating earnings estimates in recent quarters. Analyst consensus is bullish with a $329.62 price target, though valuation ratios like P/E of 37.61 and P/B of 42.85 suggest premium pricing. Recent news highlights AI potential via a partnership with Alphabet's Gemini and ongoing retail adjustments.
Outlook remains positive driven by earnings growth and AI integration, but risks include high valuation sensitivity, competitive pressures, and regulatory scrutiny. The stock offers stability with consistent cash flow and dividend payments, yet investors should weigh premium multiples against growth sustainability in a challenging macro environment.
XLV trades at $162.06, down 1.03% on the day, with technical indicators showing a bullish trend supported by moving averages while oscillators remain neutral. The healthcare ETF benefits from defensive sector positioning amid market volatility, with recent news highlighting healthcare as a safe haven during choppy markets. A dividend of $0.66 is scheduled for June 2026, providing income appeal.
Outlook remains positive given healthcare's defensive characteristics and innovation momentum in biotech and pharmaceuticals. Key risks include sector-specific regulatory pressures and patent cliff concerns for major holdings. Analyst sentiment leans bullish with technical support at $160 and resistance at $164.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Apple Inc
Apple Inc. designs, manufactures, and markets personal computers and related personal computing and mobile communication devices along with a variety of related software, services, peripherals, and networking solutions. Apple sells its products worldwide through its online stores, its retail stores, its direct sales force, third-party wholesalers, and resellers.
Read more on AAPL →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
